Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Increasing NO levels in blood as novel strategy for sickle cell disease

Oct. 21, 1999

Texas Biotechnology announces new preclinical, clinical data and future plans for sitaxsentan

Oct. 19, 1999

Teveten now available in the U.S.

Oct. 19, 1999

Texas Biotechnology presents new ETA antagonists at ET-6

Oct. 19, 1999

Cardioprotective agent JTV-519 may also prevent atrial fibrillation

Oct. 19, 1999

Long-term E-4010 improves mortality in pulmonary hypertensive rats

Oct. 19, 1999

Study in patients with severe pulmonary hypertension indicates efficacy of prostacyclin derivative

Oct. 15, 1999

MediGene in-licenses etomoxir for treatment of CHF

Oct. 15, 1999

AtheroGenics commences phase II trial for treatment of postangioplasty restenosis

Oct. 15, 1999

Funds from NIST to be used to advance Reprogenesis's lead product into clinic

Oct. 14, 1999

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...